secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scopus BioPharma Inc. (—)
CIK:        0001772028
Form:       8-K
Filed at:   2023-08-18T23:59:59+00:00
Accession:  0001104659-23-093554
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Scopus BioPharma increases authorized common shares via charter amendment
-------------------------------------------------------------------------

- Stockholders approved increase in authorized shares of common stock on August 10, 2023.
- Certificate of Amendment filed with Delaware Secretary of State, effective August 14, 2023.
- Amendment attached as Exhibit 3.1 to the 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1772028/000110465923093554/0001104659-23-093554-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1772028/000110465923093554/tm2324079d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-093554

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer